The Global IPG Buffer Market was valued at USD 83.6 Million in 2025 and is projected to reach USD 119 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period (2025–2034). This growth is being driven by the expanding field of proteomics research, rising demand for advanced analytical techniques in life sciences, and the consistent need for high-resolution protein separation in applications such as biomarker discovery and drug development.

As the life sciences industry advances toward more precise and reproducible analytical methods, the spotlight falls on the key reagent suppliers who are driving innovation, quality, and scientific accessibility. In this blog, we profile the Top 5 Companies in the IPG Buffer Industry—a mix of global life science giants and specialist electrophoresis firms shaping the future of proteomics worldwide.

---

🔟 1. Cytiva

Headquarters: Marlborough, Massachusetts, USA
Key Offering: IPG Buffer solutions for Immobilized pH Gradient isoelectric focusing, Ettan IPGphor system consumables

Cytiva, formerly part of GE Healthcare Life Sciences, stands as one of the most recognized names in the global IPG Buffer market. The company offers a comprehensive portfolio of reagents and consumables designed for two-dimensional electrophoresis workflows, with its IPG Buffer products serving as the foundation for reproducible protein separation in proteomics research. Cytiva’s extensive global distribution network and strong relationships with pharmaceutical companies, academic institutions, and contract research organizations (CROs) ensure that its IPG Buffer products are accessible to laboratories worldwide. The company’s competitive strategy centers on continuous product innovation and integrated workflow solutions that pair IPG strips, buffers, and electrophoresis instrumentation seamlessly.

Key Strengths:

• Broad product portfolio covering multiple pH ranges and buffer formulations

• Industry-leading lot-to-lot consistency critical for reproducible proteomics results

• Strong technical support infrastructure serving global research and biopharmaceutical customers

Download FREE Sample Report:
IPG Buffer Market – View in Detailed Research Report

---

9️⃣ 2. Bio-Rad Laboratories

Headquarters: Hercules, California, USA
Key Offering: ReadyStrip IPG Strips, Bio-Lyte Ampholytes, PROTEAN IEF System reagents

Bio-Rad Laboratories is a cornerstone player in the IPG Buffer market, offering a well-established line of reagents and systems for two-dimensional gel electrophoresis. The company’s Bio-Lyte carrier ampholytes and associated IPG Buffer products are widely used in academic research, biopharmaceutical quality control, and medical diagnostics. Bio-Rad’s PROTEAN IEF system represents an integrated solution that combines instrumentation and consumables, creating strong customer loyalty and reducing the likelihood of supplier switching. Because reproducibility is paramount in protein separation, Bio-Rad’s emphasis on manufacturing consistency has made it a trusted name across laboratories globally. Furthermore, the company invests heavily in application-specific support, providing researchers with detailed protocols and technical guidance for complex proteomic workflows.

Key Strengths:

• Integrated electrophoresis systems that drive sustained consumable demand

• Well-established presence in both academic and industrial laboratory segments

• Continuous investment in next-generation buffer formulations for enhanced resolution

---

8️⃣ 3. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: IPG Buffer reagents for isoelectric focusing, proteomics workflow consumables

Thermo Fisher Scientific brings the scale and breadth of the world’s largest life sciences company to the IPG Buffer market. Its extensive portfolio spans the entire proteomics workflow, from sample preparation and isoelectric focusing to downstream mass spectrometry analysis. This end-to-end capability gives Thermo Fisher a significant competitive advantage, as customers increasingly prefer suppliers who can serve multiple steps of their research pipeline. The company’s IPG Buffer products benefit from rigorous quality control standards and global manufacturing infrastructure, ensuring consistent supply to customers across North America, Europe, and Asia-Pacific. Thermo Fisher’s scale also allows it to invest substantially in R&D, producing enhanced buffer formulations that support emerging applications in clinical diagnostics and systems biology.

Key Strengths:

• End-to-end proteomics workflow solutions integrating IPG Buffer products with mass spectrometry platforms

• Global manufacturing and distribution network ensuring reliable supply chain performance

• Substantial R&D investment driving innovations in buffer chemistry and formulation stability

Download FREE Sample Report:
IPG Buffer Market – View in Detailed Research Report

---

7️⃣ 4. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Life science reagents for electrophoresis, isoelectric focusing ampholytes and buffer solutions

Merck KGaA, operating its life science division under the MilliporeSigma brand in North America, is a significant participant in the global IPG Buffer market. The company’s broad chemical and life science portfolio provides it with the raw material capabilities and formulation expertise needed to produce high-quality electrophoresis reagents. Merck’s established relationships with European pharmaceutical companies and research institutions give it a strong regional foothold, particularly in Germany, France, and the United Kingdom. The company competes effectively through deep expertise in chemical sciences and specialized product offerings that complement its wider life science consumables business. Moreover, Merck’s commitment to regulatory compliance and quality assurance ensures that its IPG Buffer products meet the stringent standards required for biopharmaceutical applications.

Key Strengths:

• Deep chemical expertise supporting proprietary buffer formulation development

• Strong European market presence with established pharmaceutical and academic customer base

• Broad life science portfolio enabling cross-selling and integrated reagent supply agreements

---

6️⃣ 5. Serva Electrophoresis GmbH

Headquarters: Heidelberg, Germany
Key Offering: SERVALYT carrier ampholytes, specialized electrophoresis reagents and IPG Buffer products

Serva Electrophoresis GmbH is a specialist supplier with a long history of expertise in electrophoresis chemistry. Unlike the larger, diversified life science corporations, Serva focuses specifically on electrophoresis reagents and related consumables, which gives it a depth of technical knowledge that is difficult to replicate. The company’s SERVALYT carrier ampholyte product line is well regarded within the scientific community for its performance in isoelectric focusing applications. Serva serves a loyal niche customer base that values specialized technical expertise and responsive customer service over the broader catalog offerings of larger competitors. However, because the company competes effectively through deep product knowledge and strong customer relationships, it has maintained a stable market position within the European market and select global accounts. Serva’s focused approach allows it to respond quickly to emerging application-specific needs, making it a valued partner for researchers working on specialized proteomic challenges.

Key Strengths:

• Specialist expertise in electrophoresis chemistry with a focused product portfolio

• High-quality SERVALYT ampholytes with a strong reputation in the European scientific community

• Responsive technical support and customized solutions for niche proteomic applications

Read Full Report:
IPG Buffer Market – View in Detailed Research Report

---

🌍 Outlook: The Future of the IPG Buffer Market Is Driven by Precision and Innovation

The IPG Buffer market is experiencing a period of steady but meaningful transformation. While the core technology of two-dimensional gel electrophoresis remains well-established, the industry is investing in next-generation buffer formulations, automated workflow integration, and application-specific solutions that address the evolving demands of modern proteomics research.

📈 Key Trends Shaping the Market:

• Rapid expansion of proteomics and genomics research investment across North America, Europe, and Asia-Pacific

• Growing demand for application-specific IPG buffers tailored to membrane proteins, low-abundance proteins, and clinical diagnostics

• Integration of IPG-based isoelectric focusing workflows with automated electrophoresis systems and high-throughput screening platforms

• Increasing biopharmaceutical R&D expenditure driving sustained demand for high-resolution protein characterization reagents

• Emerging market growth in China, India, and Brazil as governments increase life sciences research investment

Read Full Report:
IPG Buffer Market – View in Detailed Research Report

The companies profiled above are not only advancing global proteomics research—they are spearheading the next generation of precision protein analysis that will underpin drug discovery, biomarker identification, and personalized medicine for decades to come.